Weeks 9 to 12: Moving to 7.5 mg Around week nine, youll increase to 7.5 mg weekly
HypothalamicPituitary Integration: GLP-1 neurons in the arcuate nucleus project to GnRH neurons, suggesting that GLP-1 signaling may influence gonadotropin secretion
Nevertheless, the target for GIPR antagonists is believed to be a neuronal population in the brain, as a peptideantibody conjugate that blocks GIPR while activating GLP-1R required central GIPR for maximal weight loss in DIO mice, as determined using mice lacking Gipr in cells expressing synapsin 12

Try the BMI Calculator Metabolic root cause correction: By dramatically improving insulin sensitivity and glucose metabolism, tirzepatide may address the metabolic dysfunction that feeds fibromyalgia pain circuits Dual-pathway neuroinflammation reduction: Both GIP and GLP-1 receptor activation in the brain suppress microglial activation and pro-inflammatory cytokine production, potentially quieting the central sensitization that underlies fibromyalgia pain Mitochondrial function support: Improved insulin signaling and reduced oxidative stress may improve mitochondrial energy production in muscle tissue, addressing the cellular basis of fibromyalgia fatigue Breaking the pain-weight cycle: Substantial weight loss reduces mechanical pain, improves mobility, and enables the exercise that's one of fibromyalgia's most effective treatments Sleep quality improvement: Weight loss, particularly visceral fat reduction, can improve sleep apnea and sleep architecture

PlexusDx requires baseline ultrasound documentation and typically recommends annual ultrasound follow-up